Anatara Lifesciences is developing non-antibiotic oral solutions for gastrointestinal diseases in animals and humans.
Introducing Anatara’s technology
Bromelain is a mixture of proteases extracted from pineapple stems. Specific proteases within Bromelain have anti-attachment, anti-secretory and anti-inflammatory activity. Collectively, these proteases provide a broad spectrum of activity as they not only prevent the diarrhoea-causing organism from attaching to the small intestine in the first place, but they also block inflammation and the secretory action of toxins, the underlying cause of diarrhoea. Anatara is developing proprietary formulations of bromelain for the prevention and treatment of gastrointestinal diseases in animals and humans.
Anatara’s lead product, Detach, is a non-antibiotic approach to aid in the control of diarrhoeal disease (known as scour). The product has been exclusively licensed to Zoetis Inc., the leading global animal health company, for the worldwide development, manufacture, distribution and marketing of Detach for use in livestock and horses.
Anatara is developing proprietary bromelain formulations for gastrointestinal health. Further information on our human development plans will be provided in the near future.
Anatara’s team and opportunity
Backed by a well credentialed Board and Management team, and world-leading scientific collaborators, Anatara is uniquely positioned to fulfill a significant unmet medical need in gut health in humans.